NAD+ and glutathione naturally decline with age , contributing to cellular dysfunction, oxidative stress, and increased risk of chronic diseases like Alzheimer's, Parkinson's, and metabolic disorders
The efficacy, safety and tolerability of ALC were studied during a double-blind, placebo-controlled, 12-week trial in patients with initial dementia caused by AD and vascular dementia (VD)
Treatment decision-making should focus on individualised holistic treatment, requiring clinical judgement to balance the efficacy and safety of treatments with confounding health factors
Staying active can slow or prevent most age-related health problems
Combination therapies may be useful to prevent praziquantel resistance even if only partial worm reductions were affected by the new drug alone
hyaluronic acid and glycerin for hydration